Evolve Clinical Research is a multi-site network that increases the availability of clinical trials by embedding research sites within physicians' offices.

Evolve Clinical Research

AutoCruitment provides patient recruitment technology and services for clinical trials, targeting, recruiting, screening, and referring patients directly without needing provider approvals.

AutoCruitment

BBK Worldwide provides solutions for patient recruitment and engagement in clinical trials, including strategy and research, creative services, outreach services, site success services, participant travel, participant payments, decentralized services, and a patient engagement platform.

BBK Worldwide

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Metric
Company Name	Evolve Clinical Research	AutoCruitment	BBK Worldwide	ICON Public Limited Company
Symbol				ICLR
MSH ID	COM:EVOLVECLINICALRESEARCH	COM:AUTOCRUITMENT	COM:BBKWORLDWIDE	COM:ICONPLC
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Clinical Research	Clinical Research	Clinical Research	Medical - Diagnostics & Research
Country	US	US	US	IE
Stage
Employee Count				41.15K
Website	evolveclinicalresearch.com	autocruitment.com	bbkworldwide.com	iconplc.com
LinkedIn
Founders

Metric
Market Cap				27.17B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue				8.12B
Revenue (LTM)
Revenue (NTM)
Gross Profit				1.81B
EBITDA				1.69B
Operating Income				1.06B
Net Income				612.34M
EPS				7.46
Diluted EPS				7.40
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.28
Operating Profit Margin				0.13
EBITDA Margin				0.21
Net Profit Margin				0.09
Return on Equity				0.08
Return on Assets				0.04
Return on Capital Employed				0.08

EVOL

COM:EVOLVECLINICALRESEARCH

Evolve Clinical Research

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				42.50
P/B Ratio				2.44
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				3.42
EV Multiple				14.63

Metric
Days Sales Outstanding				134.60
Days Payables Outstanding				5.64
Days Inventory Outstanding				0.00
Operating Cycle				133.36
Cash Conversion Cycle				126.56
Asset Turnover				0.49

Metric
Operating Cash Flow				1.16B
Free Cash Flow				1.02B
Cash Flow to Debt				0.38
Operating Cash Flow/Sales				0.16
Free Cash Flow Yield				0.02

Metric
Cash & Equivalents				378.10M
Accounts Receivable				-78.58M
Inventory
Goodwill				9.02B
Debt to Capitalization				0.29
Debt to Assets				0.24
Current Ratio				1.19
Quick Ratio				1.31

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.01
R&D to Revenue
SG&A to Revenue